Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2005
10/06/2005US20050220762 Modified human interferon polypeptides and their uses
10/06/2005CA2560923A1 Annexin ii and uses thereof
10/06/2005CA2560696A1 Mutations of the pik3ca gene in human cancers
10/06/2005CA2559480A1 Methods and compositions for inhibition of metastasis
10/06/2005CA2558357A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
10/05/2005EP1582584A1 PROCESS FOR PRODUCING PNPase
10/05/2005EP1581797A2 Methods for the detection, analysis and isolation of nascent proteins
10/05/2005EP1581657A2 Methods for rapid identification of pathogens in humans and animals
10/05/2005EP1581650A2 Molecular signature and assay for fluoroquinoline resistance in bacillus anthracis
10/05/2005EP1581647A2 Rapid direct sequence analysis of multi-exon genes
10/05/2005EP1581644A1 Purification of polypeptides
10/05/2005EP1581638A1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
10/05/2005EP1581635A2 Sirna-mediated gene silencing
10/05/2005EP1581620A2 Antibodies that recognize hyperproliferative cells and methods of making and using same
10/05/2005EP1581610A2 Use of chimeric nucleases to stimulate gene targeting
10/05/2005EP1581553A1 Enzymes and polynucleotides encoding the same
10/05/2005EP1581548A2 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same
10/05/2005EP1581164A2 Compositions and methods for inhibiting tumor growth and metastasis
10/05/2005EP1581092A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/05/2005EP1581056A2 Therapeutic retroviral vectors for gene therapy
10/05/2005EP1470219A4 Peroxide-driven cytochrome p450 oxygenase variants
10/05/2005EP1409735A4 Dual resonance energy transfer nucleic acid probes
10/05/2005CN1678755A Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
10/05/2005CN1678738A 核酸回收芯片和核酸回收装置 Nucleic acids and nucleic acid recovery chip recovery
10/05/2005CN1678737A Nucleic acid analysis chip and nucleic acid analyzer
10/05/2005CN1678735A Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
10/05/2005CN1678618A Process for separating and deprotecting oligonucleotides
10/04/2005US6951931 Complexing pyrimidine compound with nucleic acid
10/04/2005US6951930 Hybridization-triggered fluorescent detection of nucleic acids
10/04/2005US6951928 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)
10/04/2005US6951924 Antibodies against secreted protein HTEBYII
10/04/2005US6951749 Carboxypeptidases and nucleic acids encoding same
10/04/2005US6951742 Polyclonal and monoclonal antibodies to antigens in poultry or birds, formed using polynucleotide vaccines; proteomics
10/04/2005US6951738 Human tumor necrosis factor receptors TR13 and TR14
10/04/2005US6951735 Death domain containing receptors
10/04/2005US6951722 Method for amplifying nucleic acid sequence
10/04/2005US6951720 Use of phosphorothiolate polynucleotides in ligating nucleic acids
10/04/2005US6951719 Polynucleotides formed by hybridization of oligonucleotides, then ligation with synthetases and denaturing to form complementary DNA; genetic engineering
10/04/2005US6951682 Porous coatings bearing ligand arrays and use thereof
10/04/2005US6951653 Streptococcal C5a peptidase vaccine
10/04/2005US6951648 Variant of LAV viruses
09/2005
09/29/2005WO2005090606A2 Identification of toxic nucleotide sequences
09/29/2005WO2005090378A1 Ligands of the molecule fit (agt-121) and their pharmaceutical use
09/29/2005WO2005089287A2 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/29/2005WO2005089285A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
09/29/2005WO2005089229A2 Vpac1 selective antagonists and their pharmacological methods of use
09/29/2005WO2005089123A2 Therapeutic anti-cancer dna
09/29/2005WO2005089047A2 Glycosylated glucocerebrosidase expression in fungal hosts
09/29/2005WO2005089038A2 Method for cloning, expression and purification of the amyloid polypeptide from human pancreatic islets
09/29/2005WO2005072456A3 Single use lyophilized enzymatic reagents, and kits and methods for using same
09/29/2005WO2005070104A3 REAL-TIME POLYMERASE CHAIN REACTION-BASED GENOTYPING ASSAY FOR β2-ADRENERGIC RECEPTOR SINGLE NUCLEODITE POLYMORPHISM
09/29/2005WO2005067692A3 Detection and quantification of analytes in solution using polymers
09/29/2005WO2005056752A3 Methods and compositions for delivering polynucleotides
09/29/2005WO2005023205A3 Compositions and methods for yersinia pestis treatment
09/29/2005WO2004070008A8 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
09/29/2005WO2004063355A3 Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
09/29/2005US20050216971 DNA having a nucleotide sequence encoding insecticidal proteins; chimeric genes and host cells and plants containing them
09/29/2005US20050215777 Synthesizing nucleic acid, contacting with a alkylamine, loading mixture onto media and applying a purification gradient using a suitable elution buffer; one pot deprotection; solution phase synthesis; solid phase synthesis
09/29/2005US20050215776 Expression vector comprising nucleotide sequences coding g protein coupled receptors for use in diagnosis, prevention and treatment of physiological or behavioral disorders
09/29/2005US20050215775 70 human secreted proteins
09/29/2005US20050215507 Therapeutic anti-cancer DNA
09/29/2005US20050215506 Antisense nucleotide sequences for inhibiting the expression of tyrosinase; control melanin biosynthetic pathway; treating pigment disorder of eyes, hair, and skin, and melanoma
09/29/2005US20050215505 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders
09/29/2005US20050215504 Antisense modulation of sterol regulatory element-binding protein-1 expression
09/29/2005US20050215503 HIF oligonucleotide decoy molecules
09/29/2005US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens
09/29/2005US20050214937 Surface proteins of leptospira
09/29/2005US20050214926 Adhering nucleotide sequences to solid support; gene expression analysis
09/29/2005US20050214920 Detergent composition containing the polypeptide and a surfactant; can be used in the conversion of cellulosic materials to monosaccharides, disaccharides, and polysaccharides
09/29/2005US20050214917 Thermo-stable lactate oxidase
09/29/2005US20050214906 Means and methods for regulating gene expression
09/29/2005US20050214905 Novel compounds
09/29/2005US20050214904 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders
09/29/2005US20050214901 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
09/29/2005US20050214899 Capable of removing the N-terminal Met from bulky or acidic penultimate residues
09/29/2005US20050214890 Novel "Cleave-N-Read" system for protease activity assay and methods of use thereof
09/29/2005US20050214883 Novel alanine transaminase enzyme and methods of use
09/29/2005US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/29/2005US20050214845 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
09/29/2005US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders
09/29/2005US20050214843 Propargyl substituted nucleoside compounds and methods
09/29/2005US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
09/29/2005US20050214822 Using cypin in assays, diagnostics and treatment of cognitive disorders
09/29/2005US20050214819 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/29/2005US20050214818 Using cells expressing armitage (ARMI) polypetide as models for id entifying modulators of cell proliferative disorders
09/29/2005US20050214809 Real-time detection of nucleic acids and proteins
09/29/2005US20050214808 Plant having tolerance to environmental stress
09/29/2005US20050214802 screening inhibitors of caspase interaction with a melanoma-inhibitor of apoptosis (ML-IAP) chimera; diagnosing cancer
09/29/2005US20050214797 Minor groove binders; quenchers
09/29/2005US20050214790 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of schizophrenia
09/29/2005US20050214786 26 human secreted proteins
09/29/2005US20050214784 Processes for detecting or quantifying nucleic acids using an array of fixed or immobilized nucleic acids
09/29/2005US20050214781 Ovarian specific nucleic acid (OSNA) for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; genetic vaccines
09/29/2005US20050214780 Using polymorphism in potassium channel interacting protein (KChIP1) as diagnostic indicator for pancreatic disorders
09/29/2005US20050214776 Photoprotein capable of binding coelenterazine and molecular oxygen, allows for emission of light at longer wavelengths as result of energy transfer; assay for screening HIV-1 protease inhibitors; microanalysis and drug discovery; kits
09/29/2005US20050214774 Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof
09/29/2005US20050214772 Thio modified aptamer synthetic methods and compositions
09/29/2005US20050214771 Methods for identifying risk of breast cancer and treatments thereof
09/29/2005US20050214768 Regulation of human serine/threonine kinase
09/29/2005US20050214767 Solid supports functionalised with phosphorus dendrimers, method for preparing same and uses thereof